Home a Norwood biotech gets first of three potential orphan drug designations
 

Keywords :   


a Norwood biotech gets first of three potential orphan drug designations

2015-06-13 17:54:32| Biotech - Topix.net

A 10-employee Norwood biotech has received the first of what it expects will be three orphan drug designations from the Food and Drug Administration for a drug it bought last year from a professor at UMass Medical Center in Worcester. Corbus Pharmaceuticals , which just started trading on the Nasdaq exchange in April, has been known among investors mostly for its plan to develop the drug to treat inflammation associated with cystic fibrosis which could potentially be used in conjunction with the suite of drugs being produced at Boston-based Vertex Pharmaceuticals .

Tags: potential drug biotech designations

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »